AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17877239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 15341616 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% neutral sodium fluoride (NaF) mouthrinse
Number of subjects: 369
Study 15341616 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX) mouthrinse
Number of subjects: 369
Study 15341616 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 369
Study 11605107 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-controlled robotic endoscope manipulator
Number of subjects: 0
Study 11605107 — intervention group
Group type: COMPARATOR
Intervention: Human assistant
Number of subjects: 0
Study 9825367 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg SDZ WAG994 orally
Number of subjects: 32
Study 9825367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8016791 — intervention group
Group type: COMPARATOR
Intervention: MDI alone
Number of subjects: 10
Study 8016791 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumatic spacer
Number of subjects: 10
Study 8016791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bricanyl Spacer
Number of subjects: 10
Study 8016791 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebuhaler
Number of subjects: 10
Study 8016791 — intervention group
Group type: EXPERIMENTAL
Intervention: Open mouth technique
Number of subjects: 10
Study 8016791 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI
Number of subjects: 10
Study 2562233 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium valproate (MV) 1200 mg daily
Number of subjects: 8
Study 2562233 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium valproate (MV) 400 mg single dose
Number of subjects: 8
Study 2562233 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term therapy with magnesium valproate (MV)
Number of subjects: 8
Study 50110 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicynene
Number of subjects: 76
Study 50110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 29538243 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-anchored annular closure device (ACD)
Number of subjects: 550
Study 29538243 — intervention group
Group type: COMPARATOR
Intervention: Limited lumbar discectomy only (Controls)
Number of subjects: 550
Study 27513406 — intervention group
Group type: COMPARATOR
Intervention: 0 cmH2O PEEP
Number of subjects: 75
Study 27513406 — intervention group
Group type: COMPARATOR
Intervention: 5 cmH2O PEEP
Number of subjects: 75
Study 27513406 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 cmH2O PEEP
Number of subjects: 75
Study 23701571 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit-juice drink (FJD) with 500 mL
Number of subjects: 15
Study 23701571 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (HFM-P)
Number of subjects: 15
Study 22868522 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol combination (BUD/FM) 320/9 μg/day
Number of subjects: 17
Study 22868522 — intervention group
Group type: COMPARATOR
Intervention: Budesonide plus tulobuterol patch (BUD + Tulo)
Number of subjects: 17
Study 20602006 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (AEP) on a treadmill, 3 times a week for two months
Number of subjects: 10
Study 20602006 — intervention group
Group type: COMPARATOR
Intervention: Sedentary behavior (Control Group)
Number of subjects: 10
Study 20602006 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (AEP)
Number of subjects: 10
Study 18391102 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental tobacco smoke (ETS) exposure for 1 hour
Number of subjects: 11
Study 18391102 — intervention group
Group type: COMPARATOR
Intervention: Nontobacco smoke exposure
Number of subjects: 11
Study 18391102 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual administration of nicotine
Number of subjects: 11
Study 18391102 — intervention group
Group type: EXPERIMENTAL
Intervention: ETS exposure
Number of subjects: 11
Study 18391102 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ETS and nontobacco smoke exposure
Number of subjects: 11
Study 15662072 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio prompts during CPR
Number of subjects: 24
Study 15662072 — intervention group
Group type: COMPARATOR
Intervention: No audio prompts during CPR
Number of subjects: 24
Study 15662072 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio prompts before training
Number of subjects: 24
Study 15662072 — intervention group
Group type: EXPERIMENTAL
Intervention: After training
Number of subjects: 24
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dialysis
Number of subjects: 1846
Study 12819247 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose dialysis
Number of subjects: 1846
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux dialysis membrane
Number of subjects: 1846
Study 12819247 — intervention group
Group type: COMPARATOR
Intervention: Low-flux dialysis membrane
Number of subjects: 1846
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1846
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-morbidity score
Number of subjects: 1846
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum albumin
Number of subjects: 1846
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular access-related infection
Number of subjects: 1846
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-access-related infection
Number of subjects: 1846
Study 12819247 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheters in patients with access-related infection
Number of subjects: 1846
Study 10719135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalamin level
Number of subjects: 159
Study 8799541 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical discectomy (MS)
Number of subjects: 79
Study 8799541 — intervention group
Group type: COMPARATOR
Intervention: Standard lumbar discectomy (SD)
Number of subjects: 79
Study 1346170 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol group (pHi-guided therapy)
Number of subjects: 260
Study 1346170 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard ICU practices)
Number of subjects: 260
Study 3883737 — intervention group
Group type: COMPARATOR
Intervention: Molsidomine 2 or 4 mg single oral dose
Number of subjects: 23
Study 3883737 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine 8 to 24 mg/24 hours
Number of subjects: 23
Study 31408030 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbicide candidates (various dosing mechanisms including vaginal gel, oral tablet, ring)
Number of subjects: 0
Study 31408030 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 30175792 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthan Gum (XG) added to enteral nutrient Meibalance
Number of subjects: 0
Study 30175792 — intervention group
Group type: COMPARATOR
Intervention: Control group (Meibalance without XG)
Number of subjects: 0
Study 26572722 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0
Study 26572722 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional pharmacological approaches)
Number of subjects: 0
Study 25037750 — intervention group
Group type: EXPERIMENTAL
Intervention: P-36/eCG
Number of subjects: 25
Study 25037750 — intervention group
Group type: EXPERIMENTAL
Intervention: P-36/LH2
Number of subjects: 25
Study 25037750 — intervention group
Group type: EXPERIMENTAL
Intervention: P-36/LH4
Number of subjects: 25
Study 25037750 — intervention group
Group type: COMPARATOR
Intervention: P-36 (control)
Number of subjects: 25
Study 23206451 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (steady-state)
Number of subjects: 36
Study 23206451 — intervention group
Group type: COMPARATOR
Intervention: Digoxin (steady-state)
Number of subjects: 36
Study 23206451 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin (steady-state)
Number of subjects: 36
Study 23206451 — intervention group
Group type: EXPERIMENTAL
Intervention: All drugs (alone or in combination)
Number of subjects: 36
Study 20575725 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated review group
Number of subjects: 938
Study 20575725 — intervention group
Group type: COMPARATOR
Intervention: Manual nurse review (control) group
Number of subjects: 938
Study 19102132 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP group
Number of subjects: 0
Study 19102132 — intervention group
Group type: COMPARATOR
Intervention: non-CPAP group
Number of subjects: 0
Study 16048137 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 hydroxyvitamin D3 [25(OH)D], 50 microg twice a week for 14 days (Study 1)
Number of subjects: 50
Study 16048137 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 800 IU (20 microg) daily for 12 months (Study 2)
Number of subjects: 50
Study 11993510 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (sulfasalazine and azathioprine)
Number of subjects: 35
Study 11993510 — intervention group
Group type: COMPARATOR
Intervention: Sulfasalazine monotherapy (placebo)
Number of subjects: 35
Study 10515399 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing against a constant inspiratory resistance to task failure
Number of subjects: 12
Study 10515399 — intervention group
Group type: EXPERIMENTAL
Intervention: Determination of 12‐min sustained ventilatory capacity
Number of subjects: 12
Study 10515399 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirometric and maximal inspiratory and expiratory mouth pressure measurements
Number of subjects: 12
Study 8534781 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (loading dose 5 mg/kg i.v., maintenance dose 2.5 mg/kg/12 h)
Number of subjects: 20
Study 8534781 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (loading dose 10 mg/kg i.v., maintenance dose 2.5 mg/kg/12 h)
Number of subjects: 20
Study 8534781 — intervention group
Group type: COMPARATOR
Intervention: Control healthy untreated prematures
Number of subjects: 20
Study 1940223 — intervention group
Group type: EXPERIMENTAL
Intervention: IgM ELISA test
Number of subjects: 100
Study 1940223 — intervention group
Group type: COMPARATOR
Intervention: Indirect haemagglutination test (IHA)
Number of subjects: 100
Study 6818516 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Valproate (DA)
Number of subjects: 69
Study 6818516 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone (PH)
Number of subjects: 69
Study 6818516 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PO)
Number of subjects: 69
Study 30640970 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal IOP (no suction cup)
Number of subjects: 18
Study 30640970 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP increased by 10 mm Hg
Number of subjects: 18
Study 30640970 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP increased by 20 mm Hg
Number of subjects: 18
Study 30640970 — intervention group
Group type: COMPARATOR
Intervention: Higher IOP
Number of subjects: 18
Study 27798526 — intervention group
Group type: EXPERIMENTAL
Intervention: Minigrant program to increase physical activity (PA) among youth
Number of subjects: 800
Study 25973526 — intervention group
Group type: EXPERIMENTAL
Intervention: MNTX (8 mg or 12 mg by body weight, administered every other day for two weeks)
Number of subjects: 116
Study 25973526 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered every other day for two weeks)
Number of subjects: 116
Study 24172161 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 and 20 mg/day)
Number of subjects: 40
Study 24172161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 22859237 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept 15 mg intramuscularly once weekly for 12 weeks plus nbUVB three times weekly
Number of subjects: 98
Study 22859237 — intervention group
Group type: COMPARATOR
Intervention: Alefacept 15 mg intramuscularly once weekly for 12 weeks
Number of subjects: 98
Study 19772184 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotaline (test product)
Number of subjects: 24
Study 19772184 — intervention group
Group type: COMPARATOR
Intervention: Zoloft (reference product)
Number of subjects: 24
Study 17594251 — intervention group
Group type: EXPERIMENTAL
Intervention: Case managed intervention
Number of subjects: 273
Study 17594251 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation stage at baseline
Number of subjects: 273
Study 17594251 — intervention group
Group type: EXPERIMENTAL
Intervention: Support from someone (friend, family, social worker)
Number of subjects: 273
Study 17594251 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis within 6 months of enrollment
Number of subjects: 273
Study 15226169 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medications
Number of subjects: 45
Study 15226169 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 45
Study 12587480 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium (GIK) solution
Number of subjects: 34
Study 12587480 — intervention group
Group type: COMPARATOR
Intervention: Ringer solution
Number of subjects: 34
Study 9822095 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (alpha-tocopherol acetate, 300 mg/day)
Number of subjects: 60
Study 9822095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 9690924 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (27 patients)
Number of subjects: 79
Study 9690924 — intervention group
Group type: COMPARATOR
Intervention: Control group (52 patients)
Number of subjects: 79
Study 1812902 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquafresh Flex toothbrush (soft, medium, firm bristle versions)
Number of subjects: 35
Study 1812902 — intervention group
Group type: COMPARATOR
Intervention: Standard brush with soft bristles (control)
Number of subjects: 35
Study 6342546 — intervention group
Group type: EXPERIMENTAL
Intervention: clemastine
Number of subjects: 15
Study 6342546 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 31580931 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute psychosocial stressor (n=37)
Number of subjects: 54
Study 31580931 — intervention group
Group type: COMPARATOR
Intervention: No-stress active control (n=17)
Number of subjects: 54
Study 31525613 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention program (PIP) consisting of 12 weekly group sessions.
Number of subjects: 194
Study 31525613 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control group).
Number of subjects: 194
Study 28121265 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-Alanine (6.4g∙day‐1 for six weeks)
Number of subjects: 15
Study 28121265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 28121265 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-Alanine
Number of subjects: 15
Study 27500675 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency intrapulmonary ventilation along with mineral water baths, inhalations, exercise therapy, manual massage, intake of extract maral root, and 'Yantar antiox' preparation.
Number of subjects: 49
Study 27500675 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitative treatment without high-frequency intrapulmonary ventilation.
Number of subjects: 49
Study 24894392 — intervention group
Group type: EXPERIMENTAL
Intervention: Superimposed electrical stimulation
Number of subjects: 8
Study 24894392 — intervention group
Group type: COMPARATOR
Intervention: Voluntary contraction
Number of subjects: 8
Study 23265079 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-Hz violet laser acupuncture
Number of subjects: 13
Study 23265079 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-Hz violet laser acupuncture
Number of subjects: 13
Study 23265079 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-Hz and 100-Hz violet laser acupuncture
Number of subjects: 13
Study 19939380 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 female condom
Number of subjects: 0
Study 19939380 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 female condom
Number of subjects: 0
Study 19939380 — intervention group
Group type: COMPARATOR
Intervention: Both types of female condoms
Number of subjects: 0
Study 17564852 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) classroom
Number of subjects: 20
Study 17564852 — intervention group
Group type: COMPARATOR
Intervention: Normal control
Number of subjects: 20
Study 15817723 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol ingestion (GI) - 37 ml water/l total body water plus 1.5 g glycerol/l total body water
Number of subjects: 7
Study 15817723 — intervention group
Group type: COMPARATOR
Intervention: Water ingestion (WI) - 37 ml water/l total body water
Number of subjects: 7
Study 11790937 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing from the high right atrium
Number of subjects: 0
Study 11790937 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing from novel sites (interatrial septum, Bachman bundle, dual-site or biatrial pacing)
Number of subjects: 0
Study 9345118 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 25443
Study 9345118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25443
Study 8877198 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced computerized tomography (CT) with 18G needle aspiration
Number of subjects: 40
Study 8877198 — intervention group
Group type: COMPARATOR
Intervention: 3-point permucosal 18G needle aspirations
Number of subjects: 40
Study 10277393 — intervention group
Group type: EXPERIMENTAL
Intervention: Organizational manipulations including reduced nurses' responsibility for management of patient flow and inclusion of an education checklist in the medical record
Number of subjects: 0
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: RMI (>200) in postmenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: ROMA (≥29.9) in postmenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: CA125 (>35 U/mL) in postmenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: HE4 (>140 pmol/L) in postmenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: RMI in premenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: ROMA (≥11.6) in premenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: CA125 in premenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: HE4 (>70 pmol/L) in premenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: RMI in postmenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: ROMA in postmenopausal women
Number of subjects: 638
Study 30149898 — intervention group
Group type: EXPERIMENTAL
Intervention: ROMA in premenopausal women
Number of subjects: 638
Study 26123137 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT 400 mg/d (n=61)
Number of subjects: 117
Study 26123137 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (n=56)
Number of subjects: 117
Study 24971988 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonists
Number of subjects: 2064
Study 24971988 — intervention group
Group type: COMPARATOR
Intervention: No treatment with GnRH agonists
Number of subjects: 2064
Study 22695211 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorette(®) Freshmint Gum
Number of subjects: 200
Study 22695211 — intervention group
Group type: COMPARATOR
Intervention: Nicorette(®) Microtab (tablet)
Number of subjects: 200
Study 20157322 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based behavioral treatment (intervention)
Number of subjects: 192
Study 20157322 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 192
Study 18310554 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxy consent for clinical trial enrollment (simvastatin treatment)
Number of subjects: 0
Study 18310554 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-making process for enrollment in a randomized controlled trial
Number of subjects: 0
Study 18310554 — intervention group
Group type: EXPERIMENTAL
Intervention: Research enrollment decisions made by study partners
Number of subjects: 0
Study 15976500 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Support Organiser (FSO) service
Number of subjects: 340
Study 15976500 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 340
Study 12808261 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% or greater reduction in total cholesterol
Number of subjects: 4615
Study 12808261 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol levels below 240 mg/dl (6.20 mmol/L)
Number of subjects: 4615
Study 12808261 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol levels below 220 mg/dl (5.68 mmol/L)
Number of subjects: 4615
Study 10818892 — intervention group
Group type: EXPERIMENTAL
Intervention: Mattress 1 (specific mattress not named)
Number of subjects: 25
Study 10818892 — intervention group
Group type: EXPERIMENTAL
Intervention: Lloyd Davies position
Number of subjects: 25
Study 10818892 — intervention group
Group type: COMPARATOR
Intervention: All mattresses
Number of subjects: 25
Study 8674171 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 1011
Study 8674171 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 1011
Study 8674171 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PTCA and CABG
Number of subjects: 1011
Study 1614112 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (Praxilène)
Number of subjects: 42
Study 1614112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 6734389 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked Potato
Number of subjects: 10
Study 6734389 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw Potato
Number of subjects: 10